| Literature DB >> 10050221 |
Abstract
The effect of intravenous midazolam on persistent postoperative nausea and vomiting (PONV) was compared to placebo in a prospective randomized double-blind study. Twenty patients aged 18 to 82 years with persistent PONV resistant to standard anti-emetics and present for greater than six hours were randomized to receive either an intravenous infusion of midazolam 1.0 mg/h or placebo. Nausea (P = 0.04), vomiting (P = 0.02) and the use of rescue anti-emetics (P = 0.003) were significantly less in the midazolam group. We conclude that low-dose intravenous infusion of midazolam significantly reduces persistent PONV.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10050221 DOI: 10.1177/0310057X9902700107
Source DB: PubMed Journal: Anaesth Intensive Care ISSN: 0310-057X Impact factor: 1.669